Research Article

ASSESSMENT OF DELAYS AMONGST CERVICAL CANCER PATIENTS IN A RADIOTHERAPY FACILITY: A PROSPECTIVE STUDY

1 Department of Radiology, Ahmadu Bello University Zaria, Kaduna State, Nigeria
2 Department of Radiology, Ahmadu Bello University Zaria, Kaduna State, Nigeria; Department of Radiation and Clinical Oncology, Ahmadu Bello University, Teaching Hospital, Zaria, Kaduna State, Nigeria
3 Department of Obstetrics and Gynecology, Ahmadu Bello University Teaching, Hospital, Zaria, Kaduna State, Nigeria
4 Department of Radiotherapy and Oncology, Federal Medical Centre, Abuja, FCT, Nigeria
5 Department of Obstetrics and Gynecology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria
* Corresponding author: shehuumar125@gmail.com
Published: Jan, 2025
Pages: 70-89
Views: 267
Downloads: 196

Abstract

Introduction: Globally, cervical cancer is the 8th commonest malignancy and the fourth commonest in females. However, in Sub-Saharan Africa, the incidence and mortality from cervical cancer is second only to breast cancer, and actually highest in some of the countries. Most cases of cervical cancer in Sub-Saharan Africa are diagnosed at advanced stages, largely due to the various delays. These include Presentation, Diagnostic, and Treatment delays; which together constitute Total delay.

Materials and Methods: This was a prospective study conducted amongst cervical cancer patients being managed in a tertiary health facility. Patients’ socio-demographic and clinical details were obtained using a semi structured questionnaire and staging was done using the International Federation of Obstetrics and Gynecology (FIGO) 2018 staging system. Each patient was then followed up and their delays were recorded.

Results: A total of 108 cervical cancer patients participated in the study with mean age of 53.7 ± 12.2 years, and 103(95.4%) presenting with advanced disease. The mean Presentation, Diagnostic, Treatment and Total delays were 18.9 ±15.1, 12.9 ±9.5, 10.6 ±9.5 and 42.5 ±21.9 weeks respectively. The use of traditional medication, finance and number of hospitals visited by patients before histology diagnosis; were some of the factors associated with delays.

Conclusion: There were significant delays in cervical cancer patients, with distribution of the various components of delays highlighted along with associated factors. Relevant stakeholders should implement massive health education campaigns, community-based screening, and adequate healthcare financing of cancer treatment to achieve earlier diagnosis and prompt treatment of most of cervical cancer patients.

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;0:1-41.
  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  3. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends - An update. Cancer Epidemiology Biomarkers and Prevention. 2016;25(1): 16-27.
  4. International Agency for Research on Cancer. Globocan Nigeria fact sheet 2018. https://gco.iarc.fr/today/data/factsheets/populations/566-nigeria. Accessed 4/5/2020.
  5. International Agency for Research on Cancer. Globocan Nigeria fact sheet 2020. https://gco.iarc.fr/today/data/factsheets/populations/566-nigeria. Accessed 3/3/2021.
  6. Mahantshetty U. The Role of chemotherapy in the treatment of cervical cancers. Oncology. 2007;21(5):579–86
  7. Mahantshetty U, Berger D. Prescribing, recording and reporting brachytherapy for cancer of cervix. Journal of ICRU 2013; 13 (1-2): 89
  8. World Health Organization. Guide to cancer early diagnosis, 2017. https://who.int/cancer/publications/cancer_early_diagnosis. Accessed 4/2/2020
  9. Union for International Cancer Control. Cervical cancer elimination in Africa: where we are now and where do we need to be.2022. https://www.uicc.org/news/cervical-cancer-elimination-in-africa-where-we-are-now-and-where-do-we-need-to-be Last accessed 06/01/2023
  10. Federal Ministry of Health. Nigeria cancer strategies. 2018. https://www.iccp-portal.org/system/files/plans/NCCP_Final%5B1%5D.pdf. Accessed 4/2/2020
  11. Forbes LJL, Warburton F, Richards MA, Ramirez AJ. Risk factors for delay in symptomatic presentation: A survey of cancer patients. Br J Cancer. 2014; 111(3):581-588.
  12. Anorlu RI, Orakwue CO, Oyeneyin L, Abudu OO. Late presentation of patients with cervical cancer to a tertiary hospital in Lagos: What is responsible? Eur J Gynaecol Oncol. 2004;25(6):729-732
  13. Rudd P, Gorman D, Meja S, Mtonga P, Jere Y, Chidothe I, et al. Cervical cancer in southern Malawi: A prospective analysis of presentation, management and outcomes. Malawi Med J. 2017;29(2):124-129.
  14. Ouasmani F, Hanchi Z, Haddou Rahou B, Bekkali R, Ahid S, Mesfioui A. Determinants of Patient Delay in Seeking Diagnosis and Treatment among Moroccan Women with Cervical Cancer. Obstet Gynecol Int. 2016;2016:4840762.doi:10.1155/2016/4840762.
  15. Berraho M, Obtel M, Bendahhou K, Zidouh A, Errihani H, Benider A, et al. Sociodemographic factors and delay in the diagnosis of cervical cancer in morocco. Pan Afr Med J. 2012;12:14.
  16. Lim AW, Ramirez AJ, Hamilton W, Sasieni P, Patnick J, Forbes LJL. Delays in diagnosis of young females with symptomatic cervical cancer in England: An interview-based study. British Journal of General Practice. 2014;64(627):e602-e610.
  17. Adekunle OO, Samaila MOA. Prevalence of cervical intraepithelial neoplasia in Zaria. Annals of African Medicine. 2010;9(3):194
  18. Bolarinwa OA. Sample Size Estimation for Health and Social Science Researchers: The Principles and Considerations of Different Study Designs. Nigerian Postgraduate Medical Journal. 2020; 27(2):67-75.
  19. Espina C, McKenzie F, dos-Santos-Silva I. Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Annals of Epidemiology. 2017; 27(10): 659- 671
  20. Gyenwali D, Khanal G, Paudel R, Amatya A, Pariyar J, Onta SR. Estimates of delays in diagnosis of cervical cancer in Nepal. BMC Womens Health. 2014;14(1):29
  21. Robinson KM, Christensen KB, Ottesen B, Krasnik A. Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancer. Eur J Cancer Care (Engl). 2011;20(5):653-661
  22. Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ. Risk factors for delayed presentation and referral of symptomatic cancer: Evidence for common cancers. Br J Cancer. 2009;101(Suppl 2):S92-S101.
  23. Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: A systematic review. Lancet. 1999;353(9159):1127-1131
  24. Akuoko CP, Armah E, Sarpong T, Quansah DY, Amankwaa I, Boateng D. Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa. PLoS One. 2017;12(2):e0171024.
  25. Ibrahim NA, Oludara MA. Socio-demographic factors and reasons associated with delay in breast cancer presentation: A study in Nigerian women. Breast. 2012;21(3):416-418.
  26. Kaku M, Mathew A, Rajan B. Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India. Asian Pacific J Cancer Prev. 2008;9(4):589-594.
  27. Tadesse SK. Socio-economic and cultural vulnerabilities to cervical cancer and challenges faced by patients attending care at Tikur Anbessa Hospital: A cross sectional and qualitative study. BMC Womens Health. 2015;15:75.
  28. Katz ML, Young GS, Reiter PL, Battaglia TA, Wells KJ, Sanders M, et al. Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: Impact on timely care. Women's Heal Issues. 2014;24(1):e155-e162.
  29. Piñeros M, Sánchez R, Cendales R, Perry F, Ocampo R. Patient delay among Colombian women with breast cancer. Salud Publica Mex. 2009;51(5):372-380.
  30. Ali R, Mathew A, Rajan B. Effects of socio-economic and demographic factors in delayed reporting and late-stage presentation among patients with breast cancer in a major cancer Hospital in South India. Asian Pacific J Cancer Prev. 2008;9(4):703-707.
  31. Maghous A, Rais F, Ahid S, Benhmidou N, Bellahamou K, Loughlimi H, et al. Factors influencing diagnosis delay of advanced breast cancer in Moroccan women. BMC Cancer. 2016;16:2016.
  32. Chadza E, Chirwa E, Maluwa A, Malata A, Kazembe A, Chimwaza A. Factors that contribute to delay in seeking cervical cancer diagnosis and treatment among women in Malawi. Health (Irvine Calif). 2012;04(11):1015-1022.
  33. Abiodun OA, Olu-Abiodun OO, Sotunsa JO, Oluwole FA. Impact of health education intervention on knowledge and perception of cervical cancer and cervical cancer screening uptake among adult women in rural communities in Nigeria. BMC Public Health. 2014;14:814
  34. Balogun MR, Odukoya OO, Oyediran MA, Ujomu PI. Cervical cancer awareness and preventive practices: a challenge for female urban slum dwellers in Lagos, Nigeria. Afr J Reprod Health. 2012;16(1):75-82.
  35. Ahmed S, Ahmed R, Idris S, Sabitu K. Knowledge, attitude and practice of cervical cancer screening among market women in Zaria, Nigeria. Niger Med J. 2013;54(5):316-319.
  36. Hyacinth HI, Adekeye OA, Ibeh JN, Osoba T. Cervical Cancer and Pap Smear Awareness and Utilization of Pap Smear Test among Federal Civil Servants in North Central Nigeria. PLoS One. 2012;7(10):e46583.
  37. Mbamara SU, Ikpeze OC, Okonkwo JEN, Onyiaorah I V., Ukah CO. Knowledge, Attitude and Practice of Cervical Cancer Screening Among Women Attending Gynecology Clinics in a Tertiary Level Medical Care Center in Southeastern Nigeria. J Reprod Med Obstet Gynecol. 2011;56(11-12):491-496.
  38. Farooqui M, Hassali MA, Shatar AKA, Farooqui MA, Saleem F, Haq N ul, et al. Use of complementary and alternative medicines among Malaysian cancer patients: A descriptive study. J Tradit Complement Med. 2015;6(4):321-326.
  39. Hunter D, Oates R, Gawthrop J, Bishop M, Gill S. Complementary and alternative medicine use and disclosure amongst Australian radiotherapy patients. Support Care Cancer. 2014;22(6):1671-1578.
  40. Stewart TS, Moodley J, Walter FM. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Cancer Epidemiol. 2018;53:81-92.
  41. Pillay AL. Rural and urban South African women's awareness of cancers of the breast and cervix. Ethn Heal. 2002;7(2):103-114.
  42. Price AJ, Ndom P, Atenguena E, Mambou Nouemssi JP, Ryder RW. Cancer care challenges in developing countries. Cancer. 2012;118(14):3627-3635.
  43. Moodley M. Cervical cancer in Southern Africa: The challenges. South African J Gynaecol Oncol. 2009;1(1):11-13.
  44. Clegg-Lamptey J, Dakubo J, Attobra YN. Why do breast cancer patients report late or abscond during treatment in Ghana? A pilot study. Ghana Med J. 2009;43(3):127-131.
  45. Dunyo P, Effah K, Udofia E. Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study. BMC Public Health. 2018; 18:1-10
  46. Federal Ministry of Health: National Health Policy 2016: Promoting the Health of Nigerians to Accelerate Socio-economic Development. 2016: 26- 37
  47. World Health Organisation.Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications-detail-redirect/9789240014107. Last accessed 06/01/2023.
How to Cite

Umar, S. S., Abdullahi, A., Ahmad, A. J., Ahmadu, O. T., & Yahya, A. (2025). ASSESSMENT OF DELAYS AMONGST CERVICAL CANCER PATIENTS IN A RADIOTHERAPY FACILITY: A PROSPECTIVE STUDY. Nigerian Journal of Oncology, 1(1), 70-89. https://doi.org/10.67579/njo.2025.gnod4e8a

S. S. Umar, A. Abdullahi, A. J. Ahmad, O. T. Ahmadu, and A. Yahya, "ASSESSMENT OF DELAYS AMONGST CERVICAL CANCER PATIENTS IN A RADIOTHERAPY FACILITY: A PROSPECTIVE STUDY," Nigerian Journal of Oncology, vol. 1, no. 1, pp. 70-89, January 2025. doi: 10.67579/njo.2025.gnod4e8a

Share this article:
Facebook X / Twitter LinkedIn